Condition
Seroma as Procedural Complication
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07620184Not ApplicableRecruiting
Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery
NCT06575049Not Yet Recruiting
Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery
NCT03166384Not ApplicableCompletedPrimary
ELectrosurgical Bipolar Devices VS Conventional Electro-cauterization in Breast Surgery
NCT04229940Phase 2Completed
Peritoneal in Laparoscopic Ventral Hernia Repair 2
NCT04554407Not ApplicableUnknownPrimary
Study to Evaluate the Performance of a Sustained Vacuum System
Showing all 5 trials